Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure ...

Biond Biologics Ltd., a private clinical-stage biotechnology company developing first-in-class immunotherapies for cancer and immune-mediated diseases, and the Guangzhou-Israel Biotechnology Fund ...

Emphasizes Importance of Experienced Biotech Leadership as Vaxart AdvancesClinical and Strategic Priorities with Multiple Value-Creating ...

UAS-B introduces innovative UG programmes in Natural Farming, Forestry, and Biotechnology to meet emerging educational and ...

CBDT has granted scientific research approval to a biotechnology institution under the Income-tax Act, 2025. Eligible donations made during tax years 2026-27 to 2030-31 may qualify for prescribed tax ...

This clinical-stage biotech develops precision genetic medicines for neurological and hepatic disorders via its PRISM platform.

When life gives you lemons, you make pillows. That’s just the case for a Massachusetts entrepreneur who turned a canceled birthday party into a successful business. And her slogan is: "Forget diamonds ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor ...

A team of researchers led by Luigi Naldini at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) has developed a ...

Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust clinical pipeline.

A team of researchers led by Luigi Naldini at the San Raffael Institute for Gene Therapy (SR-Tiget) has developed a new ...

Akeso's ivonescimab reduces death risk by 34% in phase three lung cancer trial, the first Chinese drug selected for ASCO's plenary in 61 years, targeting a $20B market.